Clinical Scorecard: Development of the Mainz Resilience Assessment for Pediatric Cancer: A New Age-Specific Patient-Reported Outcome Tool to Evaluate Resilience in Young Cancer Patients

At a Glance

Key Highlights

• Children with cancer face multiple disease- and treatment-related stressors that increase risk for mental health impairments.
• Resilience is conceptualized as the ability to maintain or rapidly recover mental health during and after stressor exposure, operationalized prospectively.
• Existing resilience measures lack age- and disease-specificity and fail to capture dynamic intra-treatment fluctuations in pediatric oncology.

Guideline-Based Recommendations

Diagnosis

• Use repeated, prospective assessments of cancer treatment-specific and everyday stressors alongside mental health measures to evaluate resilience.
• Calculate stressor-reactivity scores by residualizing mental health symptoms on stressor load to identify individual resilience levels.

Management

• Identify patients with persistent distress through longitudinal monitoring to target psychosocial interventions effectively.
• Incorporate patient-reported outcome tools tailored to pediatric oncology to capture dynamic resilience processes during treatment.

Monitoring & Follow-up

• Implement frequent stressor and mental health monitoring (e.g., FRESHMO paradigm) to track resilience as a dynamic process over time.
• Assess both cancer-specific stressors (e.g., pain, health anxiety) and everyday challenges (e.g., peer isolation, missed schooling) regularly.

Risks

• Failure to monitor resilience dynamically may miss patients at risk for persistent psychosocial distress during active treatment.
• Relying on retrospective or proxy assessments limits understanding of resilience fluctuations and may impair timely intervention.

Patient & Prescribing Data

Children and adolescents aged 0-19 undergoing active cancer treatment

Psychosocial resilience supports treatment adherence, quality of life, and long-term mental health; dynamic assessment enables identification of those needing targeted support.

Clinical Best Practices

• Adopt age- and disease-specific patient-reported outcome tools to measure resilience in pediatric oncology.
• Use longitudinal, prospective designs linking stressor exposure to mental health outcomes for accurate resilience assessment.
• Incorporate multidimensional assessment capturing personal traits, psychosocial functioning, and disease-specific factors.
• Engage patients directly in self-reporting to improve sensitivity to intra-treatment changes and reduce reliance on proxy reports.

References

• Kalisch et al. - Frequent Stressor and Mental Health Monitoring (FRESHMO) paradigm
• Luthar et al. (2000) - Conceptualizing resilience as dynamic adaptation
• Systematic review on resilience measures in pediatric cancer